Radresiq, Inc.
Budget
Not declared
EP Access
0
accredited persons
Staff
3
0.45 FTE
EU Grants
None
Mission & Goals
RadResIQ Inc. is a specialized biotechnology organization dedicated to advancing global standards in radiation emergency preparedness and public health response. Our mission is to bridge critical operational capability gaps through rigorous scientific research, data-driven intelligence, and the deployment of our patented MiRAD® high-throughput technology. Built upon more than 10 years of peer-reviewed research and extensive cross-species validation, RadResIQ focuses on the productization of scalable diagnostic assay solutions designed to protect healthcare infrastructure and optimize the distribution of medical countermeasures (MCMs) during large-scale radiological incidents. We are committed to collaborating with international health authorities and regulatory bodies to establish robust, validated frameworks for population-scale radiation screening and systemic resilience against emerging radiological threats.
EU Legislative Interests
RadResIQ Inc. actively monitors and seeks to contribute to the implementation of the EU Global Health Strategy and the Union Civil Protection Mechanism (UCPM), with a specific focus on CBRN (Chemical, Biological, Radiological, and Nuclear) Resilience and cross-border health threat preparedness. Our primary interest is technical engagement with the Health Emergency Preparedness and Response Authority (HERA), Emergency Readiness & Response Office. We aim to provide expert technical briefing on how the MiRAD® ETX platform—grounded in over a decade of validated, high-throughput qPCR research—can bridge the 24-hour Medical Countermeasure (MCM) operational capability gap in large-scale population screening. By aligning with the 2026 HERA CBRN Resilience Agenda, RadResIQ seeks to share data-driven insights on scalable diagnostic infrastructure to support the EU’s strategic autonomy in radiological response, ensuring that European healthcare systems are equipped with peer-reviewed, quantitative dose-reconstruction (Gy) capabilities to protect citizens and optimize the EU’s strategic stockpiles
Communication Activities
RadResIQ Inc. engages in high-level strategic and technical communication aimed at supporting EU health emergency preparedness and the CBRN Resilience Agenda.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
RadResIQ is an active participant in the international radiation research community with formal ties to key academic and research institutions. We maintain a significant association with The Ohio State University (OSU) and its Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (The James Comprehensive Cancer Center); specifically, RadResIQ is the exclusive license holder for its biodosimetry patents held by the university. Additionally, we are a member of the Radiation Research Society (RadRes) and maintain a professional association with the Institute of Radiobiology of the German Armed Forces (Bundeswehr Institute of Radiobiology) for planned exploratory evaluations. Through these memberships and agreements, we contribute technical and scientific expertise to advance global standards in radiation biodosimetry.
Organisation Members
RadResIQ is a standalone organization and does not have members. There are no other affiliated legal entities or subsidiaries to declare under this registration.
Commissioner Meetings
No recorded meetings with EU commissioners.